May 28th 2024, 5:00pm
During my time with cancer, I've come across words associated with cancer that I don't like and some that I appreciate.
May 28th 2024, 3:00pm
Treatment with Pluvicto following ARPI resulted in favorable progression and response outcomes in PSMA-positive mCRPR.
May 23rd 2024, 3:00pm
Whole-pelvic radiation conferred a 67% lower risk of all-cause mortality among patients younger than 65 with unfavorable-risk prostate cancer.
May 17th 2024, 3:00pm
From Olivia Munn opening up about undergoing a hysterectomy and egg retrieval to Michael McDonald’s learned lesson after his wife’s cancer, here’s what’s going on in the oncology space this week.
May 16th 2024, 7:00pm
The postsurgical combination of androgen deprivation therapy and Erleada has shown promising results in prostate cancer.
May 8th 2024, 7:00pm
A novel delivery system of gemcitabine called TAR-200 led to promising responses in certain patients with non-muscle-invasive bladder cancer.
May 8th 2024, 3:00pm
The Food and Drug Administration granted a Biologics License Application for subcutaneous Opdivo for potential approval.
May 6th 2024, 7:00pm
Treatment with a certain radiation therapy worsens quality of life in patients with prostate cancer. An expert explains ways to mitigate side effects.
May 2nd 2024, 5:00pm
After recovering from testicular cancer, I feel as though I've earned a second life where I face my fears head-on.
April 30th 2024, 7:00pm
A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer.
Jumping Out of Planes, Getting Tattoos and Just Being Me After Cancer
Understanding How GIST Is Diagnosed and What Patients Should Know
Fotivda Alone Maintained Quality of Life in Kidney Cancer Study
Hiking Through Breast Cancer Treatment